Form C-AR — Deverra Therapeutics, Inc.
0001665160-24-000561 · filed Apr 26, 2024
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1822782
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 2033 6th Ave Suite 600
Seattle, WA 28121 - Phone
- —
Most recent fiscal year financials
- Total assets
- $7,153,621
- Cash
- —
- Short-term debt
- $7,222,643
- Long-term debt
- —
- Revenues
- $1,677,259
- COGS
- $1,677,259
- Taxes paid
- —
- Net income
- $1,672,096
View the original filing on SEC EDGAR ↗